Update on the medical treatment of Graves’ ophthalmopathy
International Journal of General Medicine, 2009 Gregory J Griepentrog, James A GarrityDepartment of Ophthalmology, Mayo Clinic, Rochester, MN, USAPurpose: To review recent advances in the understanding of Graves’ ophthalmopathy (GO) pathogenesis as well as discuss current and future medical ...
Gregory J Griepentrog, James A Garrity
doaj
Hyperthyroid heart disease: Diagnostic and therapeutic aspects [PDF]
, 1990 Reinwein, Dankwart +2 more
core +1 more source
TEMPORAL RELATIONSHIP BETWEEN THE ONSET OF THYROID DERMOPATHY AND GRAVES' OPHTHALMOPATHY
Acta Medica Iranica, 1993 Pretibial myxedema is an uncommon manifestation of Graves' disease and because of its rarity, information regarding its natural course and its relationship with other manifestations of Graves' disease is not sufficient.
Mohammad Pajhouhi
doaj
Effects of treatment modalities for Graves' hyperthyroidism on Graves' orbitopathy: a 2015 Italian Society of Endocrinology Consensus Statement. [PDF]
, 2015 Bartalena L +4 more
core +1 more source
Euthyroid Graves' Ophthalmopathy With Negative Antibodies (EGONA): A Comprehensive Case-Based Review. [PDF]
CureusBonny M +6 more
europepmc +1 more source
Clinical value of dual-energy CT parameters combined with morphological features in predicting graves' ophthalmopathy. [PDF]
BMC Med ImagingMa Z +7 more
europepmc +1 more source
New-Onset Graves' Ophthalmopathy After Treatment with Pembrolizumab: A Case Report and a Review of the Literature. [PDF]
Diagnostics (Basel)Pan M, Zhou X, Wu Y.
europepmc +1 more source
Isolation and initial characterization of microvascular endothelial cells derived from the retoorbital connective tissue of patients with Graves ophthalmopathy [PDF]
, 1994 Bahn, R. S. +2 more
core +1 more source
Emerging therapeutic approaches in graves' ophthalmopathy: an update on pharmacological interventions. [PDF]
Front ImmunolWang L, Chen L.
europepmc +1 more source